Natticha Sumneang

Myeloid differentiation factor 2 in the heart: Bench to bedside evidence for potential clinical benefits?

Natticha Sumneang, Nattayaporn Apaijai, Siriporn C. Chattipakorn et al. · Pharmacological Research · 2020 · 23 citations

Heart Failure, Cardiovascular Translational Research, Potential Clinical Benefits +10

Combined iron chelator with N-acetylcysteine exerts the greatest effect on improving cardiac calcium homeostasis in iron-overloaded thalassemic mice

Natticha Sumneang, Sirinart Kumfu, Juthamas Khamseekaew et al. · Toxicology · 2019 · 19 citations

Cardiovascular Toxicity, Heart Failure, Cardiac Calcium Homeostasis +12

Inhibition of myeloid differentiation factor 2 attenuates cardiometabolic impairments via reducing cardiac mitochondrial dysfunction, inflammation, apoptosis and ferroptosis in prediabetic rats

Natticha Sumneang, Thura Tun Oo, Kodchanan Singhanat et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2021 · 19 citations

Inflammation, Metabolic Syndrome, Prediabetic Rats +13

Effectiveness of high cardiorespiratory fitness in cardiometabolic protection in prediabetic rats

Chanisa Thonusin, Patcharapong Pantiya, Natticha Sumneang et al. · Molecular Medicine · 2022 · 15 citations · Full text

Therapeutic potential of a single-dose melatonin in the attenuation of cardiac ischemia/reperfusion injury in prediabetic obese rats

Kodchanan Singhanat, Nattayaporn Apaijai, Natticha Sumneang et al. · Cellular and Molecular Life Sciences · 2022 · 12 citations · Full text

Metabolic Syndrome, Cardiac Ischemia/reperfusion Injury, Cardiovascular Disease +12